Klp Kapitalforvaltning As Dyne Therapeutics, Inc. Transaction History
Klp Kapitalforvaltning As
- $20.6 Billion
- Q4 2024
A detailed history of Klp Kapitalforvaltning As transactions in Dyne Therapeutics, Inc. stock. As of the latest transaction made, Klp Kapitalforvaltning As holds 10,900 shares of DYN stock, worth $145,624. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,900Holding current value
$145,624% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding DYN
# of Institutions
209Shares Held
102MCall Options Held
234KPut Options Held
238K-
Atlas Venture Life Science Advisors, LLC8.02MShares$107 Million31.16% of portfolio
-
Black Rock Inc. New York, NY7.39MShares$98.7 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY6.82MShares$91.1 Million3.9% of portfolio
-
Janus Henderson Group PLC London, X06.81MShares$91 Million0.13% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.7MShares$89.6 Million0.0% of portfolio
About Dyne Therapeutics, Inc.
- Ticker DYN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 51,765,400
- Market Cap $692M
- Description
- Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...